Profile
Christiaan de Wilde is currently the Chief Executive Officer at Fujirebio Europe NV, and also holds the position of Co-Managing Director at Fujirebio Germany GmbH.
In the past, he worked as a Director at Janssen-Cilag International NV and as Director-Finance & Logistics at Johnson & Johnson Medical, Inc. from 2000 to 2005.
Christiaan de Wilde active positions
| Companies | Position | Start |
|---|---|---|
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Chief Executive Officer | 2005-12-31 |
Fujirebio Germany GmbH
 Fujirebio Germany GmbH Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Germany GmbH develops and manufactures pharmaceutical products. The private company is based in Hannover, Germany. The CEO of the company is Christiaan de Wilde. | Chief Executive Officer | - |
Former positions of Christiaan de Wilde
| Companies | Position | End |
|---|---|---|
Johnson & Johnson Medical, Inc.
 Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a private company that manufactures surgical appliances. The company is based in Arlington, TX. | Director of Finance/CFO | 2005-04-30 |
Janssen-Cilag International NV
 Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the private company since 2009. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Janssen-Cilag International NV
Janssen-Cilag International NV BiotechnologyHealth Technology Part of Johnson & Johnson, Janssen-Cilag International NV is a Belgian company that develops novel medicines and solutions. Bart Willem van Zijll Langhout has been the CEO of the private company since 2009. | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
Johnson & Johnson Medical, Inc.
Johnson & Johnson Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Johnson & Johnson Medical, Inc. is a private company that manufactures surgical appliances. The company is based in Arlington, TX. | Health Technology |
Fujirebio Germany GmbH
Fujirebio Germany GmbH Pharmaceuticals: MajorHealth Technology Part of H.U. Group Holdings, Inc., Fujirebio Germany GmbH develops and manufactures pharmaceutical products. The private company is based in Hannover, Germany. The CEO of the company is Christiaan de Wilde. | Health Technology |
- Stock Market
- Insiders
- Christiaan de Wilde
